More People Are Surviving Lung Cancer Than Ever Before: One Survivor Shares His Story

Updated November 26th, 2021

More People Are Surviving Lung Cancer Than Ever Before: One Survivor Shares His Story

New study shows deaths from non-small cell lung cancer have dropped sharply in the last decade. Treatment advancements are the reason. Larry Whipple is a beneficiary.

NOW
PLAYING
Overview of Stage Four Lung Cancer
NOW
PLAYING
Clinical Trials and What Statistics Really Mean
NOW
PLAYING
Radiation for Advanced Lung Cancer
NOW
PLAYING
Comprehensive Biomarker Testing for Lung Cancer Points Docs to the Right Drug
NOW
PLAYING
Radiation Boom--The Increasingly Popular Choice For Later Stage Cancer
NOW
PLAYING
New Data at ASCO: Encouraging Results For Immunotherapy in Advanced Non-Small Cell Lung Cancer

Later Stage Treatment: The Importance of Biomarker Testing

SEE MORE   

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.

Later Stage Treatment: The Importance of Biomarker Testing

  • Changes in cancer cells are called biomarkers and can affect treatment.
  • In lung cancer, there are two sets of biomarkers: driver mutations and PDL1.
  • Normal cells become cancer cells because of driver mutations. PDL1 on cancer cells stops your immune system from killing them.
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.